Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M108,522Revenue $M42,750Net Margin (%)17.6Z-Score2.1
Enterprise Value $M133,394EPS $1.8Operating Margin %22.5F-Score6
P/E(ttm))16.2Cash Flow Per Share $0Pre-tax Margin (%)21.0Higher ROA y-yY
Price/Book13.210-y EBITDA Growth Rate %3.2Quick Ratio0.7Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %2.6Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %-27.4ROA % (ttm)10.4Higher Current Ratio y-yN
Dividend Yield %5.9Insider Buy (3m)0ROE % (ttm)68.0Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M4,804ROI % (ttm)14.0Gross Margin Increase y-yN

Gurus Latest Trades with GLAXF

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

GLAXF is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


GLAXF: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$1288.25 view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$1461.36 view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$1288.25 view

Press Releases about GLAXF :

    Quarterly/Annual Reports about GLAXF:

      News about GLAXF:

      Articles On GuruFocus.com
      Tweedy Browne Global Value Fund's Top Picks for Q3 Oct 21 2014 
      Diamond Hill Capital Comments on GlaxoSmithKline PLC Oct 17 2014 
      Dodge & Cox’ Stock Fund Third Quarter 2014 Commentary Oct 16 2014 
      Ebola: Is The Cure Out There? Oct 14 2014 
      Guru Stocks at 52-Week Lows: GE, BHP, TOT, BP, GSK Oct 12 2014 
      Guru Stocks at 52-Week Lows: BHP, GSK, UTX, SAP, TEF Sep 30 2014 
      International Securities For A Diversified Income Portfolio Sep 23 2014 
      Widely Held Guru Stocks Trading In Europe Sep 22 2014 
      Guru Stocks at 52-Week Lows: BHP, GSK, EC, VALE, ABB Sep 21 2014 
      Guru Stocks at 52-Week Lows: BHP, GSK, VOD, LYG, TEF Sep 16 2014 

      More From Other Websites
      Big pharma battles charge of tardiness on Ebola Oct 24 2014
      Success of HIV drug highlighted by GSK plan to float unit Oct 24 2014
      Retailers lead FTSE 100 losses Oct 23 2014
      Big business tempers anti-graft clampdown, says report Oct 23 2014
      U.S. tightens Ebola monitoring for West African visitors Oct 22 2014
      GLOBAL MARKETS-Shares falter as Wall St tumbles; bond prices fall Oct 22 2014
      GLOBAL MARKETS-Shares falter as Wall St tumbles, bond prices fall Oct 22 2014
      GSK's Witty fights back with strong message to shareholders Oct 22 2014
      GLOBAL MARKETS-Shares rally on corporate results; bond prices fall Oct 22 2014
      GSK expects first doses of Ebola vaccine ready by year end Oct 22 2014
      U.S. tightens Ebola monitoring for West African visitors Oct 22 2014
      Motor insurers help Britain's FTSE to end higher Oct 22 2014
      Motor insurers help Britain's FTSE to end higher Oct 22 2014
      GSK restructuring to include potential float of HIV unit Oct 22 2014
      GLOBAL MARKETS-Shares rally on corporate results, bond prices fall Oct 22 2014
      GlaxoSmithKline's mulled HIV spin-off 'bigger than M&S and Sainsbury's combined' Oct 22 2014
      Motor insurers help Britain's FTSE edge higher Oct 22 2014
      Drugmaker GSK announces big cost cuts after profit slump Oct 22 2014
      GSK sees first Ebola vaccine doses ready late this year Oct 22 2014
      Ebola crisis 'unlikely to be under control within a year', says pharma boss Oct 22 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK